Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of RPL36 protein | CTD | PMID:31195006 | (1->4)-beta-D-glucan | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL36 mRNA | CTD | PMID:36331819 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | RPL36 (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to RPL36 protein | CTD | PMID:32991956 | 17beta-estradiol | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of RPL36 mRNA | CTD | PMID:23019147 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Rpl36 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPL36 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL36 mRNA | CTD | PMID:33387578 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of RPL36 mRNA | CTD | PMID:28522335 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of RPL36 mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of RPL36 mRNA | CTD | PMID:18648102 | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of RPL36 protein | CTD | PMID:33236894 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPL36 mRNA | CTD | PMID:16483693 | antimycin A | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Antimycin A results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | aristolochic acid A | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RPL36 protein | CTD | PMID:33212167 | arsane | affects methylation | ISO | RPL36 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RPL36 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RPL36 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RPL36 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPL36 mRNA] | CTD | PMID:32406909 | azoxystrobin | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | azoxystrobin results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | benzo[a]pyrene | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to RPL36 promoter] | CTD | PMID:19654925 | benzo[a]pyrene | increases methylation | ISO | RPL36 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of RPL36 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RPL36 mRNA | CTD | PMID:20504355 and PMID:27195522 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RPL36 promoter | CTD | PMID:23359474 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RPL36 promoter | CTD | PMID:23359474 | bisphenol A | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of RPL36 protein | CTD | PMID:34186270 | bisphenol A | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RPL36 mRNA | CTD | PMID:35598803 | bisphenol A | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL36 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RPL36 protein | CTD | PMID:37567409 | bisphenol A | increases expression | ISO | Rpl36 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RPL36 mRNA | CTD | PMID:38074096 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RPL36 mRNA | CTD | PMID:32145629 | bisphenol A | affects expression | ISO | RPL36 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RPL36 mRNA | CTD | PMID:30903817 | Bisphenol B | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of RPL36 protein | CTD | PMID:34186270 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of RPL36 mRNA | CTD | PMID:19167457 | cadmium atom | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL36 mRNA | CTD | PMID:36114956 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of RPL36 promoter | CTD | PMID:22457795 | cadmium dichloride | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL36 mRNA | CTD | PMID:36114956 | caffeine | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Caffeine results in increased expression of RPL36 protein | CTD | PMID:31195006 | chloropicrin | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of RPL36 mRNA | CTD | PMID:26352163 | chromium(6+) | affects expression | ISO | Rpl36 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of RPL36 mRNA | CTD | PMID:28472532 | cisplatin | decreases response to substance | ISO | RPL36 (Homo sapiens) | 6480464 | RPL36 protein results in decreased susceptibility to Cisplatin | CTD | PMID:16394183 | clofibrate | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of RPL36 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RPL36 mRNA] | CTD | PMID:17585979 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of RPL36 mRNA | CTD | PMID:20187946 | cyclosporin A | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of RPL36 mRNA | CTD | PMID:20106945 | deguelin | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | deguelin results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RPL36 promoter | CTD | PMID:23359474 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of RPL36 mRNA | CTD | PMID:29391264 | enzyme inhibitor | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL36 protein | CTD | PMID:23301498 | epoxiconazole | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of RPL36 mRNA | CTD | PMID:35436446 | fenpyroximate | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | fulvestrant | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL36 gene | CTD | PMID:31601247 | hydralazine | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL36 mRNA | CTD | PMID:17183730 | inulin | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL36 mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RPL36 protein | CTD | PMID:32959892 | N-nitrosodiethylamine | increases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of RPL36 mRNA | CTD | PMID:12771043 | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of RPL36 mRNA | CTD | PMID:19041683 | N-nitrosomorpholine | decreases expression | EXP | | 6480464 | N-nitrosomorpholine results in decreased expression of RPL36 protein | CTD | PMID:19716841 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of RPL36 mRNA | CTD | PMID:26720608 | paracetamol | affects expression | ISO | Rpl36 (Mus musculus) | 6480464 | Acetaminophen affects the expression of RPL36 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of RPL36 mRNA | CTD | PMID:29067470 | paracetamol | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of RPL36 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RPL36 mRNA] | CTD | PMID:17585979 | parathion | increases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Parathion results in increased expression of RPL36 mRNA | CTD | PMID:34813904 | perfluorononanoic acid | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of RPL36 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rpl36 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL36 mRNA more ... | CTD | PMID:36331819 | PhIP | decreases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of RPL36 mRNA | CTD | PMID:15215175 | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of RPL36 mRNA | CTD | PMID:15215175 | picoxystrobin | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of RPL36 mRNA | CTD | PMID:28903501 | pyrimidifen | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | rotenone | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Rotenone results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | SB 431542 | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL36 protein | CTD | PMID:37664457 | senecionine | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | senecionine results in decreased expression of RPL36 protein | CTD | PMID:35357534 | sodium arsenite | decreases expression | ISO | RPL36 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RPL36 protein | CTD | PMID:30528433 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of RPL36 mRNA | CTD | PMID:35314868 | sodium fluoride | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of RPL36 protein | CTD | PMID:28918527 | stigmasterol | decreases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Stigmasterol results in decreased expression of RPL36 mRNA | CTD | PMID:30245210 | sunitinib | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of RPL36 mRNA | CTD | PMID:31533062 | tebufenpyrad | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RPL36 mRNA | CTD | PMID:33512557 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of RPL36 mRNA | CTD | PMID:15963342 | tris(2-butoxyethyl) phosphate | increases expression | ISO | RPL36 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate results in increased expression of RPL36 mRNA | CTD | PMID:29024780 | tungsten | increases expression | ISO | Rpl36 (Mus musculus) | 6480464 | Tungsten results in increased expression of RPL36 mRNA | CTD | PMID:30912803 | valproic acid | multiple interactions | ISO | RPL36 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL36 mRNA | CTD | PMID:17183730 | valproic acid | increases methylation | ISO | RPL36 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of RPL36 gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RPL36 mRNA | CTD | PMID:23034163 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of RPL36 mRNA | CTD | PMID:22615374 | |